TABLE 3.

Proportions of patients with nevirapine Cmins <6,000 ng/ml and ≥6,000 ng/ml

Elevation of Cmin (ng/ml)No. (%) of patientsa
Ishak group 1Ishak group 2Ishak group 3Overall
Total19 (100.0)20 (100.0)9 (100.0)48 (100.0)
<6,000b14 (73.7)12 (60.0)5 (55.6)31 (64.6)
≥6,000b5 (26.3)8 (40.0)4 (44.4)17 (35.4)
  • a Ishak group 1, noncirrhotic patients; Ishak group 2, noncirrhotic patients; Ishak group 3, cirrhotic patients (Child-Pugh score A).

  • b The nevirapine Cmins were not statistically significantly associated (P = 0.5731).